RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
1 Year Est. Return
+164.17%
AUM
$1.51B
AUM Growth
+$152M
(+11%)
Holding
39
Top Buys
| 1 | +$172M | |
| 2 | +$25.3M | |
| 3 | +$10.1M | |
| 4 |
ALX Oncology
ALXO
|
+$8.95M |
| 5 |
Prime Medicine
PRME
|
+$6.05M |
Top Sells
| 1 | +$30M | |
| 2 | +$27.7M | |
| 3 | +$10.7M | |
| 4 |
IDEAYA Biosciences
IDYA
|
+$7.41M |
| 5 |
Nurix Therapeutics
NRIX
|
+$5.99M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Scholar Rock
SRRK
$5.91B
| $446M | 29.51% |
9,066,621
+3,845,775
|
|
||
2
Krystal Biotech
KRYS
$9.11B
| $174M | 11.52% |
673,505
-4,200
|
|
||
3
Stoke Therapeutics
STOK
$1.93B
| $136M | 8.98% |
4,164,120
+130,050
|
|
||
4
Immunome
IMNM
$2.47B
| $122M | 8.05% |
5,558,885
-159,500
|
|
||
|
5
Nurix Therapeutics
NRIX
$1.84B
| $120M | 7.94% |
7,732,808
-361,100
|
|
||
6
Annexon
ANNX
$888M
| $80.6M | 5.34% |
14,549,768
+4,499,124
|
|
||
7
ADC Therapeutics
ADCT
$432M
| $58M | 3.84% |
15,470,502
-196,229
|
|
||
8
Regenxbio
RGNX
$362M
| $36.6M | 2.42% |
4,368,804
|
|
||
9
Shattuck Labs
STTK
$456M
| $35.6M | 2.36% |
5,539,724
|
|
||
10
Beam Therapeutics
BEAM
$3.39B
| $29.5M | 1.95% |
1,237,659
-48,200
|
|
||
11
Neurogene
NGNE
$448M
| $29.4M | 1.95% |
1,459,599
|
|
||
12
Cogent Biosciences
COGT
$5.97B
| $26.5M | 1.75% |
688,036
-749,882
|
|
||
13
Absci
ABSI
$1.05B
| $24.8M | 1.64% |
8,253,316
|
|
||
|
14
IDEAYA Biosciences
IDYA
$2.59B
| $17.4M | 1.15% |
521,117
-220,900
|
|
||
|
15
ALX Oncology
ALXO
$256M
| $16M | 1.06% |
7,964,188
+4,699,470
|
|
||
16
Fate Therapeutics
FATE
$331M
| $15.4M | 1.02% |
12,872,946
|
|
||
17
Xenon Pharmaceuticals
XENE
$5.29B
| $15.3M | 1.01% |
262,674
+128,792
|
|
||
18
Solid Biosciences
SLDB
$723M
| $14.5M | 0.96% |
2,011,895
+151,353
|
|
||
19
Nuvation Bio
NUVB
$1.66B
| $13.5M | 0.9% |
3,153,256
-10,000
|
|
||
20
Zymeworks
ZYME
$1.85B
| $12.3M | 0.82% |
491,654
|
|
||
|
SLN
21
Silence Therapeutics
SLN
$326M
| $11.4M | 0.76% |
2,164,777
|
|
||
|
DBVT
22
DBV Technologies
DBVT
$1.13B
| $10.3M | 0.68% |
491,340
-58,500
|
|
||
23
BioMarin Pharmaceuticals
BMRN
$11.1B
| $9.82M | 0.65% |
+173,859
|
|
||
24
Celldex Therapeutics
CLDX
$2.47B
| $8.3M | 0.55% |
261,508
-21,800
|
|
||
|
CBLL
25
CeriBell Inc
CBLL
$700M
| $7.09M | 0.47% |
386,786
-48,453
|
|